In conclusion, we have advanced our understanding of cancer cell-ECM interaction through identifying that both type I collagen and fibronectin are involved in the proliferation and migration of esophageal cancer cells and that knocking down these two proteins can act in synergy with chemotherapeutic drugs in reducing the growth and migration of cancer cells. This evidence concerns the gene FN1 and esophageal cancer.